Turning science into
life-changing
biotherapies
We accelerate the development of innovative, life-changing biotherapies.
A proven track record in biotherapy innovation
We combine scientific excellence with entrepreneurial execution to advance a diversified portfolio of biotherapy companies. Our platform accelerates early innovation, de-risks development, and creates repeatable value for partners, patients, and investors.
Immunotherapy
Multifactorial immune activators designed to improve efficacy and safety in next-generation treatments for cancer, immunology, and inflammation.
Cell therapy
Engineered cell therapies for solid tumors, optimized for feasibility, manufacturability, and accelerated clinical translation.
Vectorized
Precision radiopharmaceutical and vectorized chemotherapy that deliver proven therapeutic payloads with greater accuracy and reduced biological risk.
Regenerative aesthetics & medicine
Biotherapies that repair, rejuvenate, and enhance tissues, enabling differentiated, fast-moving innovations in longevity and aesthetic medicine.
A diversified portfolio of biotherapy companies
Our portfolio spans multiple biotherapy verticals supported by rigorous science, strong leadership, and a repeatable value-creation platform.
Invest in the future of biotherapies
By investing in Remora Biotech, you gain access to a diversified portfolio of high-growth biotherapy companies guided by scientific and entrepreneurial leaders with scientific expertise.